shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo - Net Worth and Insider Trading

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Net Worth

The estimated net worth of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo is at least $226 Million dollars as of 2025-07-23. shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 20,909,600 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $226 Million. Details can be seen in shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo has not made any transactions after 2024-10-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .

Click here to see the complete history of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo’s form 4 insider trades.

Insider Ownership Summary of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

Ticker	Company	Transaction Date	Type of Owner
HKSE:01541	ImmuneOnco Biopharmaceuticals (Shanghai) Inc	2024-10-25	2101 Beneficial owner

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Latest Holdings Summary

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo currently owns a total of 1 stock. shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo owns 20,909,600 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of October 24, 2024, with a value of $226 Million.

Latest Holdings of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01541	ImmuneOnco Biopharmaceuticals (Shanghai) Inc	2024-10-24	20,909,600	10.82	226,241,872

Holding Weightings of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Form 4 Trading Tracker

According to the SEC Form 4 filings, shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 3,165,000 shares on October 24, 2024, which brought shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo around $19 Million.

Insider Trading History of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Ownership Network

Ownership Network List of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

No Data

Ownership Network Relation of shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Owned Company Details

What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?

Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include 2201 Interest of corporation controlled by you jia xing han ning qi ye guan li you xian gong si , 2501 Other Tian Wenzhi , and 2201 Interest of corporation controlled by you Yu Xiaoyong .

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary

Over the past 18 months, shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 3,165,000. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net purchase of 150,000 shares made by Tian Wenzhi , a net sale of 0 shares made by shang hai zhang jiang ke ji chuang ye tou zi you xian gong si , and a net sale of 0 shares made by jia xing han ning qi ye guan li you xian gong si .

In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,165,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 3,015,000 shares.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions

No Available Data

shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo Mailing Address

Above is the net worth, insider trading, and ownership report for shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo. Currently GuruFocus does not have mailing address information for shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.